FDA Inspection 962359 — Saint Luke's Hospital of Kansas City
The FDA completed an inspection of Saint Luke's Hospital of Kansas City on March 16, 2016 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 16, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Kansas City, MO (United States)